Stegostoma fasciatum isolate 6-17 chromosome 40, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039266.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
neuropeptide Y receptor Y8b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
neuropeptide Y receptor Y8b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome c oxidase subunit 5B, mitochondrial
COORDINATES: polyA evidence [ECO:0006239]
KAT8 regulatory NSL complex subunit 3, transcript variant X4
KAT8 regulatory NSL complex subunit 3, transcript variant X2
KAT8 regulatory NSL complex subunit 3, transcript variant X3
KAT8 regulatory NSL complex subunit 3, transcript variant X1
KAT8 regulatory NSL complex subunit 3 isoform X4
KAT8 regulatory NSL complex subunit 3 isoform X2
KAT8 regulatory NSL complex subunit 3 isoform X3
KAT8 regulatory NSL complex subunit 3 isoform X1
KAT8 regulatory NSL complex subunit 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 3 isoform X5
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X2
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X3
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X1
ubiquitin-conjugating enzyme E2 D4-like isoform X2
ubiquitin-conjugating enzyme E2 D4-like isoform X3
ubiquitin-conjugating enzyme E2 D4-like isoform X1
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 D4-like isoform X4
transcription factor 7-like 2, transcript variant X2
transcription factor 7-like 2, transcript variant X1
transcription factor 7-like 2 isoform X2
transcription factor 7-like 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trans-Golgi network integral membrane protein TGN38-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle and apoptosis regulator protein 1-like, transcript variant X6
cell division cycle and apoptosis regulator protein 1-like, transcript variant X4
cell division cycle and apoptosis regulator protein 1-like, transcript variant X5
cell division cycle and apoptosis regulator protein 1-like, transcript variant X1
cell division cycle and apoptosis regulator protein 1-like, transcript variant X2
cell division cycle and apoptosis regulator protein 1-like, transcript variant X3
cell division cycle and apoptosis regulator protein 1-like isoform X4
cell division cycle and apoptosis regulator protein 1-like isoform X2
cell division cycle and apoptosis regulator protein 1-like isoform X3
cell division cycle and apoptosis regulator protein 1-like isoform X1
uncharacterized LOC125447935, transcript variant X1
uncharacterized LOC125447935, transcript variant X3
uncharacterized LOC125447935, transcript variant X2
uncharacterized protein LOC125447935 isoform X1
uncharacterized protein LOC125447935 isoform X2
PDZ and LIM domain 2 (mystique), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
PDZ and LIM domain 2 (mystique), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
PDZ and LIM domain 2 (mystique), transcript variant X2
sorbin and SH3 domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sorbin and SH3 domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sorbin and SH3 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sorbin and SH3 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sorbin and SH3 domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sorbin and SH3 domain containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
aspartate dehydrogenase domain containing, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
calcium-activated potassium channel subunit alpha-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
aspartate dehydrogenase domain containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aspartate dehydrogenase domain containing, transcript variant X4
aspartate dehydrogenase domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aspartate dehydrogenase domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aspartate dehydrogenase domain containing, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aspartate dehydrogenase domain-containing protein isoform X1
aspartate dehydrogenase domain-containing protein isoform X2
AT-rich interactive domain-containing protein 5B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
polysaccharide biosynthesis domain containing 1, transcript variant X1
polysaccharide biosynthesis domain containing 1, transcript variant X2
docking protein 2-like, transcript variant X1
docking protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GDNF family receptor alpha-2-like, transcript variant X2
GDNF family receptor alpha-2-like isoform X2
GDNF family receptor alpha-2-like, transcript variant X1
GDNF family receptor alpha-2-like isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
germ cell-less, spermatogenesis associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
germ cell-less, spermatogenesis associated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
germ cell-less protein-like 1 isoform X1
germ cell-less protein-like 1 isoform X2
aspartate aminotransferase, cytoplasmic-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aspartate aminotransferase, cytoplasmic-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aspartate aminotransferase, cytoplasmic-like, transcript variant X1
aspartate aminotransferase, cytoplasmic-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aspartate aminotransferase, cytoplasmic-like isoform X4
aspartate aminotransferase, cytoplasmic-like isoform X3
aspartate aminotransferase, cytoplasmic-like isoform X1
aspartate aminotransferase, cytoplasmic-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
small nuclear ribonucleoprotein polypeptide G
leucine zipper putative tumor suppressor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4, transcript variant X5
phosphatidylethanolamine-binding protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4 isoform X4
phosphatidylethanolamine-binding protein 4 isoform X2
phosphatidylethanolamine-binding protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4, transcript variant X4
phosphatidylethanolamine-binding protein 4, transcript variant X1
phosphatidylethanolamine-binding protein 4 isoform X3
phosphatidylethanolamine-binding protein 4 isoform X1
rho-related BTB domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho-related BTB domain-containing protein 2-like isoform X1
rho-related BTB domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho-related BTB domain-containing protein 2-like isoform X2
eukaryotic translation initiation factor 4E-binding protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
ash2 like, histone lysine methyltransferase complex subunit
set1/Ash2 histone methyltransferase complex subunit ASH2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
steroidogenic acute regulatory protein, mitochondrial
phospholipid phosphatase 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phospholipid phosphatase 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phospholipid phosphatase 4-like, transcript variant X6
phospholipid phosphatase 4-like, transcript variant X3
phospholipid phosphatase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid phosphatase 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phospholipase DDHD2-like, transcript variant X5
phospholipase DDHD2-like, transcript variant X3
phospholipase DDHD2-like, transcript variant X1
phospholipase DDHD2-like, transcript variant X2
phospholipase DDHD2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: matrix metalloproteinase-21-like
uncharacterized LOC125447995, transcript variant X1
uncharacterized LOC125447995, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 28-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 47% coverage of the annotated genomic feature by RNAseq alignments
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
Ras association domain family member 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Ras association domain family member 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Ras association domain family member 2a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Ras association domain family member 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Ras association domain family member 2a, transcript variant X3
ras association domain-containing protein 2a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidate cytidylyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidate cytidylyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phosphatidate cytidylyltransferase 2 isoform X1
phosphatidate cytidylyltransferase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 23 member 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 23 member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
solute carrier family 23 member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 23 member 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 23 member 2-like isoform X1
solute carrier family 23 member 2-like isoform X2
glutamine--fructose-6-phosphate transaminase 1, transcript variant X2
glutamine--fructose-6-phosphate transaminase 1, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like
AP2 associated kinase 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AP2 associated kinase 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
AP2 associated kinase 1b, transcript variant X3
AP2 associated kinase 1b, transcript variant X2
AP2 associated kinase 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
AP2-associated protein kinase 1 isoform X4
AP2-associated protein kinase 1 isoform X5
AP2-associated protein kinase 1 isoform X3
AP2-associated protein kinase 1 isoform X2
AP2-associated protein kinase 1 isoform X1
AP2 associated kinase 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AP2 associated kinase 1b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AP2-associated protein kinase 1 isoform X7
AP2-associated protein kinase 1 isoform X6
pituitary homeobox 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pituitary homeobox 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pituitary homeobox 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
netrin receptor UNC5D-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
netrin receptor UNC5D-like, transcript variant X1
netrin receptor UNC5D-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
netrin receptor UNC5D-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 2-like isoform X1
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 3-like isoform X2
E3 ubiquitin-protein ligase MARCHF5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 267 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 267 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X2
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X3
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X1
receptor expression-enhancing protein 1-like, transcript variant X3
receptor expression-enhancing protein 1-like, transcript variant X2
receptor expression-enhancing protein 1-like, transcript variant X1
receptor expression-enhancing protein 1-like, transcript variant X4
receptor expression-enhancing protein 1-like isoform X1
receptor expression-enhancing protein 4-like isoform X2
leucine-rich repeat transmembrane neuronal protein 4-like, transcript variant X1
leucine-rich repeat transmembrane neuronal protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 4-like isoform X1
leucine-rich repeat transmembrane neuronal protein 4-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dihydropyrimidinase-related protein 2, transcript variant X3
dihydropyrimidinase-related protein 2, transcript variant X2
dihydropyrimidinase-related protein 2, transcript variant X1
dihydropyrimidinase-related protein 2 isoform X3
dihydropyrimidinase-related protein 2 isoform X2
dihydropyrimidinase-related protein 2 isoform X1
protein phosphatase 2, regulatory subunit B, alpha a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein phosphatase 2, regulatory subunit B, alpha a, transcript variant X2
protein phosphatase 2, regulatory subunit B, alpha a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
transcription factor COE2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor COE2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor COE2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor COE2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell division cycle associated 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cell division cycle associated 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle associated 2, transcript variant X2
cell division cycle associated 2, transcript variant X7
cell division cycle associated 2, transcript variant X1
cell division cycle associated 2, transcript variant X5
cell division cycle associated 2, transcript variant X6
cell division cycle-associated protein 2 isoform X6
cell division cycle-associated protein 2 isoform X3
cell division cycle-associated protein 2 isoform X2
cell division cycle-associated protein 2 isoform X1
cell division cycle-associated protein 2 isoform X4
cell division cycle-associated protein 2 isoform X5
probable ATP-dependent RNA helicase DDX56
transmembrane emp24 domain-containing protein 4
cytosolic purine 5'-nucleotidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like isoform X2
cytosolic purine 5'-nucleotidase-like isoform X1
cytosolic purine 5'-nucleotidase-like isoform X3
sodium-dependent phosphate transporter 1-like, transcript variant X1
sodium-dependent phosphate transporter 1-like, transcript variant X4
sodium-dependent phosphate transporter 1-like, transcript variant X3
sodium-dependent phosphate transporter 1-like, transcript variant X2
sodium-dependent phosphate transporter 1-like
small nuclear ribonucleoprotein 200 (U5), transcript variant X1
small nuclear ribonucleoprotein 200 (U5), transcript variant X2
U5 small nuclear ribonucleoprotein 200 kDa helicase isoform X1
U5 small nuclear ribonucleoprotein 200 kDa helicase isoform X2
cytosolic iron-sulfur assembly component 1, transcript variant X1
cytosolic iron-sulfur assembly component 1, transcript variant X2
probable cytosolic iron-sulfur protein assembly protein ciao1 isoform X2
probable cytosolic iron-sulfur protein assembly protein ciao1 isoform X1
gamma-glutamyl hydrolase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gamma-glutamyl hydrolase-like isoform X3
inositol 1,4,5-trisphosphate receptor-interacting protein-like, transcript variant X2
inositol 1,4,5-trisphosphate receptor-interacting protein-like, transcript variant X1
inositol 1,4,5-trisphosphate receptor-interacting protein-like isoform X1
inositol 1,4,5-trisphosphate receptor-interacting protein-like isoform X2
gamma-glutamyl hydrolase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gamma-glutamyl hydrolase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
gamma-glutamyl hydrolase-like isoform X1
gamma-glutamyl hydrolase-like isoform X2
ring finger protein 122, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ring finger protein 122, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ring finger protein 122, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
V-type proton ATPase subunit B, brain isoform
glucokinase (hexokinase 4), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucokinase (hexokinase 4), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myosin regulatory light chain 2, atrial isoform
polymerase (DNA directed), delta 2, regulatory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ELMO/CED-12 domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X5
inactive carboxypeptidase-like protein X2
ELMO/CED-12 domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ELMO domain-containing protein 3 isoform X1
ELMO domain-containing protein 3 isoform X2
glycerol-3-phosphate acyltransferase 1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X1
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X2
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X3
uncharacterized protein LOC767682 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
lysoplasmalogenase-like protein TMEM86A, transcript variant X2
lysoplasmalogenase-like protein TMEM86A, transcript variant X1
lysoplasmalogenase-like protein TMEM86A isoform X2
lysoplasmalogenase-like protein TMEM86A isoform X1
glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID), b
polymerase (DNA directed), mu, transcript variant X1
polymerase (DNA directed), mu, transcript variant X3
polymerase (DNA directed), mu, transcript variant X2
DNA-directed DNA/RNA polymerase mu isoform X1
DNA-directed DNA/RNA polymerase mu isoform X3
DNA-directed DNA/RNA polymerase mu isoform X2
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X1
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X3
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X4
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X6
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X5
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X2
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X7
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X8
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X9
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X3
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X5
calcium/calmodulin-dependent protein kinase type II delta chain isoform X7
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X2
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X8
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X9
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X34
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X10
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X11
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X36
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X35
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X18
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X23
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X13
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X37
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X27
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X15
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X12
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X14
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X31
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X17
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X16
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X20
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X26
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X22
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X28
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X21
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X19
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X25
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X24
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X32
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X30
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X29
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X33
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X34
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X36
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X35
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X37
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X18
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X27
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X23
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X31
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X10
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X11
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X13
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X15
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X12
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X17
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X21
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X14
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X19
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X25
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X16
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X20
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X24
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X29
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X26
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X32
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X22
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X28
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X30
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X33
mitochondrial ribosomal protein S24, transcript variant X1
mitochondrial ribosomal protein S24, transcript variant X2
28S ribosomal protein S24, mitochondrial isoform X1
28S ribosomal protein S24, mitochondrial isoform X2
nuclear receptor binding SET domain protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X5
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X2
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X3
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X4
LETM1 domain-containing protein LETM2, mitochondrial isoform X1
LETM1 domain-containing protein LETM2, mitochondrial isoform X2
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X6
LETM1 domain-containing protein LETM2, mitochondrial isoform X3
fibroblast growth factor receptor 1-like, transcript variant X1
fibroblast growth factor receptor 1-like, transcript variant X4
fibroblast growth factor receptor 1-like, transcript variant X5
fibroblast growth factor receptor 1-like, transcript variant X6
fibroblast growth factor receptor 1-like, transcript variant X3
fibroblast growth factor receptor 1-like, transcript variant X2
fibroblast growth factor receptor 1-like isoform X4
fibroblast growth factor receptor 1-like isoform X3
fibroblast growth factor receptor 1-like isoform X2
fibroblast growth factor receptor 1-like isoform X1
transforming, acidic coiled-coil containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transforming, acidic coiled-coil containing protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transforming, acidic coiled-coil containing protein 1, transcript variant X2
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming, acidic coiled-coil containing protein 1, transcript variant X5
transforming, acidic coiled-coil containing protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transforming, acidic coiled-coil containing protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X5
pleckstrin homology domain-containing family A member 2-like, transcript variant X2
pleckstrin homology domain-containing family A member 2-like, transcript variant X1
pleckstrin homology domain-containing family A member 2-like isoform X2
pleckstrin homology domain-containing family A member 2-like isoform X1
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 9-like isoform X1
disintegrin and metalloproteinase domain-containing protein 9-like isoform X2
disintegrin and metalloproteinase domain-containing protein 9-like isoform X3
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 9-like isoform X4
indoleamine 2,3-dioxygenase 1, transcript variant X2
indoleamine 2,3-dioxygenase 1, transcript variant X1
transcriptional and immune response regulator-like
zinc finger matrin-type protein 4-like, transcript variant X2
zinc finger matrin-type protein 4-like, transcript variant X5
zinc finger matrin-type protein 4-like, transcript variant X1
zinc finger matrin-type protein 4-like, transcript variant X3
zinc finger matrin-type protein 4-like isoform X2
zinc finger matrin-type protein 4-like isoform X1
zinc finger matrin-type protein 4-like isoform X3
zinc finger matrin-type protein 4-like isoform X5
zinc finger matrin-type protein 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger matrin-type protein 4-like isoform X4
secreted frizzled-related protein 1-like, transcript variant X2
secreted frizzled-related protein 1-like, transcript variant X1
secreted frizzled-related protein 1-like isoform X2
secreted frizzled-related protein 1-like isoform X1
hexokinase-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hexokinase-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 144 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-adducin-like, transcript variant X3
beta-adducin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
beta-adducin-like, transcript variant X4
beta-adducin-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
beta-adducin-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125448033, transcript variant X2
uncharacterized LOC125448033, transcript variant X1
uncharacterized LOC125448033, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small nuclear ribonucleoprotein 27 (U4/U6.U5)
U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcriptional activator protein Pur-alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125448072, transcript variant X1
uncharacterized LOC125448072, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC125448072, transcript variant X3
uncharacterized protein LOC125448072 isoform X1
uncharacterized protein LOC125448072 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125447909, transcript variant X1
uncharacterized LOC125447909, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PH and SEC7 domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
surfactant protein Bb, transcript variant X1
surfactant protein Bb, transcript variant X2
ubiquitin specific peptidase 39, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ubiquitin specific peptidase 39, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
U4/U6.U5 tri-snRNP-associated protein 2 isoform X1
U4/U6.U5 tri-snRNP-associated protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
methionine adenosyltransferase II, alpha b
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: vitamin K-dependent gamma-carboxylase
vesicle-associated membrane protein 8 (endobrevin)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ring finger protein 181, transcript variant X1
ring finger protein 181, transcript variant X2
E3 ubiquitin-protein ligase RNF181 isoform X1
E3 ubiquitin-protein ligase RNF181 isoform X2
peptidyl-prolyl cis-trans isomerase-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase-like isoform X2
peptidyl-prolyl cis-trans isomerase-like isoform X1
zinc finger MIZ domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
2-oxoglutarate dehydrogenase complex component E1, transcript variant X5
2-oxoglutarate dehydrogenase complex component E1, transcript variant X3
2-oxoglutarate dehydrogenase complex component E1, transcript variant X1
2-oxoglutarate dehydrogenase complex component E1, transcript variant X6
2-oxoglutarate dehydrogenase complex component E1, transcript variant X4
2-oxoglutarate dehydrogenase complex component E1, transcript variant X2
2-oxoglutarate dehydrogenase complex component E1 isoform X4
2-oxoglutarate dehydrogenase complex component E1 isoform X2
2-oxoglutarate dehydrogenase complex component E1 isoform X1
2-oxoglutarate dehydrogenase complex component E1 isoform X5
2-oxoglutarate dehydrogenase complex component E1 isoform X3
StAR-related lipid transfer (START) domain containing 7, transcript variant X2
StAR-related lipid transfer (START) domain containing 7, transcript variant X3
uncharacterized LOC125447990, transcript variant X3
uncharacterized LOC125447990, transcript variant X1
uncharacterized LOC125447990, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00599
StAR-related lipid transfer (START) domain containing 7, transcript variant X4
StAR-related lipid transfer (START) domain containing 7, transcript variant X5
StAR-related lipid transfer (START) domain containing 7, transcript variant X1
stAR-related lipid transfer protein 7, mitochondrial
dual specificity protein phosphatase 1-B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD9, transcript variant X1
BTB/POZ domain-containing protein KCTD9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD9 isoform X1
BTB/POZ domain-containing protein KCTD9, transcript variant X3
BTB/POZ domain-containing protein KCTD9 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
inositol polyphosphate-5-phosphatase A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NPC1-like intracellular cholesterol transporter 1
rab11 family-interacting protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
rab11 family-interacting protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
rab11 family-interacting protein 1-like isoform X2
rab11 family-interacting protein 1-like isoform X1
prolactin-releasing peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 136 member A, transcript variant X1
family with sequence similarity 136 member A, transcript variant X2
family with sequence similarity 136 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytotoxic granule associated RNA binding protein TIA1-like
chromosome 40 C2orf42 homolog, transcript variant X1
chromosome 40 C2orf42 homolog, transcript variant X2
ankyrin repeat domain 39, transcript variant X1
ankyrin repeat domain 39, transcript variant X3
ankyrin repeat domain-containing protein 39 isoform X1
ankyrin repeat domain-containing protein 39 isoform X3
ankyrin repeat domain 39, transcript variant X2
ankyrin repeat domain-containing protein 39 isoform X2
ankyrin repeat domain 39, transcript variant X4
ankyrin repeat domain-containing protein 39 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
VIP36-like protein, transcript variant X2
VIP36-like protein, transcript variant X1
metal transporter CNNM4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
metal transporter CNNM4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
metal transporter CNNM4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
metal transporter CNNM3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
metal transporter CNNM3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
metal transporter CNNM3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
metal transporter CNNM3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phytanoyl-CoA hydroxylase-interacting protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
polymerase (RNA) III (DNA directed) polypeptide D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
polymerase (RNA) III (DNA directed) polypeptide D, transcript variant X1
DNA-directed RNA polymerase III subunit RPC4 isoform X1
DNA-directed RNA polymerase III subunit RPC4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
WW domain-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WW domain-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
WW domain-binding protein 1-like isoform X1
WW domain-binding protein 1-like isoform X2
outer mitochondrial transmembrane helix translocase-like, transcript variant X5
outer mitochondrial transmembrane helix translocase-like, transcript variant X1
outer mitochondrial transmembrane helix translocase-like, transcript variant X6
outer mitochondrial transmembrane helix translocase-like, transcript variant X2
outer mitochondrial transmembrane helix translocase-like, transcript variant X4
outer mitochondrial transmembrane helix translocase-like, transcript variant X3
outer mitochondrial transmembrane helix translocase-like isoform X1
outer mitochondrial transmembrane helix translocase-like isoform X2
cGMP-dependent protein kinase 1-like, transcript variant X1
cGMP-dependent protein kinase 1-like, transcript variant X2
cGMP-dependent protein kinase 1-like isoform X1
cGMP-dependent protein kinase 1-like isoform X2
cGMP-dependent protein kinase 1-like, transcript variant X3
cGMP-dependent protein kinase 1-like, transcript variant X4
cGMP-dependent protein kinase 1-like isoform X3
voltage-dependent anion channel 3, transcript variant X1
voltage-dependent anion channel 3, transcript variant X2
voltage-dependent anion-selective channel protein 3 isoform X2
voltage-dependent anion-selective channel protein 3 isoform X1
polymerase (DNA directed), beta, transcript variant X1
polymerase (DNA directed), beta, transcript variant X2
enkurin domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
enkurin domain containing 1, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
plasminogen activator, tissue, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
plasminogen activator, tissue, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
plasminogen activator, tissue, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
plasminogen activator, tissue, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
plasminogen activator, tissue, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tissue-type plasminogen activator isoform X1
tissue-type plasminogen activator isoform X2
tissue-type plasminogen activator isoform X3
uncharacterized LOC125448146, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125448146, transcript variant X3
uncharacterized LOC125448146, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125448146, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC125448146 isoform X4
uncharacterized protein LOC125448146 isoform X3
uncharacterized protein LOC125448146 isoform X2
uncharacterized protein LOC125448146 isoform X1
STAM-binding protein-like, transcript variant X1
STAM-binding protein-like, transcript variant X2
RNA/RNP complex-1-interacting phosphatase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transcription factor IIIB 50 kDa subunit-like, transcript variant X2
transcription factor IIIB 50 kDa subunit-like, transcript variant X3
transcription factor IIIB 50 kDa subunit-like, transcript variant X1
transcription factor IIIB 50 kDa subunit-like isoform X1
transcription factor IIIB 50 kDa subunit-like isoform X2
FHF complex subunit HOOK interacting protein 2A-like, transcript variant X3
FHF complex subunit HOOK interacting protein 2A-like, transcript variant X2
FHF complex subunit HOOK interacting protein 2A-like, transcript variant X1
FHF complex subunit HOOK interacting protein 2A-like isoform X2
FHF complex subunit HOOK interacting protein 2A-like isoform X1
actin filament-associated protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
actin filament-associated protein 1-like, transcript variant X2
actin filament-associated protein 1-like 2 isoform X1
actin filament-associated protein 1-like isoform X2
dematin actin binding protein, transcript variant X6
dematin actin binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dematin actin binding protein, transcript variant X4
dematin actin binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
leucine-rich repeat LGI family, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat LGI family, member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat LGI family member 3 isoform X1
leucine-rich repeat LGI family member 3 isoform X2
leucine-rich repeat LGI family, member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat LGI family member 3 isoform X3
charged multivesicular body protein 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
charged multivesicular body protein 7, transcript variant X2
charged multivesicular body protein 7 isoform X1
charged multivesicular body protein 7 isoform X2
DNA replication complex GINS protein SLD5
protein phosphatase 1 regulatory subunit 3C-like
nudix (nucleoside diphosphate linked moiety X)-type motif 18, transcript variant X3
nudix (nucleoside diphosphate linked moiety X)-type motif 18, transcript variant X1
nudix (nucleoside diphosphate linked moiety X)-type motif 18, transcript variant X2
G protein-coupled receptor kinase 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
U6 snRNA-associated Sm-like protein LSm1
phosphatidylinositide phosphatase SAC2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BAG family molecular chaperone regulator 3-like
histone acetyltransferase KAT6A-like, transcript variant X2
histone acetyltransferase KAT6A-like, transcript variant X3
histone acetyltransferase KAT6A-like, transcript variant X1
histone acetyltransferase KAT6A-like, transcript variant X4
histone acetyltransferase KAT6A-like isoform X1
histone acetyltransferase KAT6A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
methylcytosine dioxygenase TET3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methylcytosine dioxygenase tet3-like isoform X1
methylcytosine dioxygenase TET3-like, transcript variant X3
methylcytosine dioxygenase TET3-like, transcript variant X2
uncharacterized LOC125448144, transcript variant X3
uncharacterized LOC125448144, transcript variant X2
uncharacterized LOC125448144, transcript variant X1
methylcytosine dioxygenase TET3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
methylcytosine dioxygenase TET3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
methylcytosine dioxygenase TET3-like, transcript variant X5
methylcytosine dioxygenase TET3-like, transcript variant X7
methylcytosine dioxygenase TET3-like isoform X2
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X4
heterogeneous nuclear ribonucleoprotein H3-like isoform X1
heterogeneous nuclear ribonucleoprotein H3-like isoform X2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase, transcript variant X2
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase, transcript variant X1
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase, transcript variant X4
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X1
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X4
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase, transcript variant X3
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase, transcript variant X5
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X3
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X5
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X4
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X2
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X6
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X5
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X1
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X12
electrogenic sodium bicarbonate cotransporter 4-like isoform X10
electrogenic sodium bicarbonate cotransporter 4-like isoform X3
electrogenic sodium bicarbonate cotransporter 4-like isoform X2
electrogenic sodium bicarbonate cotransporter 4-like isoform X8
electrogenic sodium bicarbonate cotransporter 4-like isoform X6
electrogenic sodium bicarbonate cotransporter 4-like isoform X5
electrogenic sodium bicarbonate cotransporter 4-like isoform X1
electrogenic sodium bicarbonate cotransporter 4-like isoform X9
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X10
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X7
electrogenic sodium bicarbonate cotransporter 4-like isoform X7
electrogenic sodium bicarbonate cotransporter 4-like isoform X4
tetraspanin-15-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tetraspanin-15-like, transcript variant X1
tetraspanin-15-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tetraspanin-15-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns